High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

Detalles Bibliográficos
Autores principales: Palich, R., Veyri, M., Vozy, A., Marot, S., Gligorov, J., Benderra, M.-A., Maingon, P., Morand-Joubert, L., Adjoutah, Z., Marcelin, A.-G., Spano, J.-P., Barrière, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217700/
https://www.ncbi.nlm.nih.gov/pubmed/34171494
http://dx.doi.org/10.1016/j.annonc.2021.06.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217700/
https://www.ncbi.nlm.nih.gov/pubmed/34171494
http://dx.doi.org/10.1016/j.annonc.2021.06.018

Ejemplares similares